-
GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36
Monday, May 2, 2016 - 12:25pm | 328Anavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical stage biopharmaceutical company that focuses on the development of drugs to treat Alzheimer's CNS diseases and other types of cancer which have significant unmet medical needs. According to GeoInvesting, Anavex is merely a "penny...